08.10.2013 16:39:40

McKesson Reportedly In Advance Talks To Buy Celesio; Shares Up

(RTTNews) - The U.S. Drug distribution company McKesson Corp. (MCK) is in advance talks with majority shareholder of German drug distributor Celesio AG (CAKFF.PK) to buy the German drug distributor for more than 3.74 billion euros or $5.08 billion, the Wall Street Journal reported citing people familiar with the matter.

McKesson has gained access to the books of Celesio. If McKesson decides to go ahead, it may announce a bid as early as this month, the paper said citing the people.

An offer, should McKesson decide to make one, could include a premium of up to around 30%, near 22 euros per share, or 3.74 billion euros, the Journal reported quoting two of these people. McKesson would also assume Celesio debt, putting the company's enterprise value-equity and debt- about 5.38 billion euros.

The paper said that under a likely deal structure, McKesson would launch a voluntary takeover offer for all Celesio shares, with majority shareholder, the Franz Haniel & Cie GmbH, having agreed to tender its stake.

MCK is currently trading at $135.43, up $5.80 or 4.48%.

Analysen zu McKesson Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

McKesson Corp. 570,80 -0,56% McKesson Corp.